Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
M Mahdi‐Rogers, R Brassington… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
disease that causes progressive or relapsing and remitting weakness and numbness. It is …
disease that causes progressive or relapsing and remitting weakness and numbness. It is …
Epidemiology of paraneoplastic neurological syndromes: a population-based study
A Vogrig, GL Gigli, S Segatti, E Corazza, A Marini… - Journal of …, 2020 - Springer
Background The epidemiology of paraneoplastic neurological syndromes (PNS) remains to
be defined. We present here the first population-based incidence study and report the …
be defined. We present here the first population-based incidence study and report the …
Androgen-induced cardiovascular risk in polycystic ovary syndrome: the role of T lymphocytes
M Moulana - Life, 2023 - mdpi.com
An estimated 15–20% of reproductive-age women are affected by polycystic ovary
syndrome (PCOS). PCOS is associated with substantial metabolic and cardiovascular long …
syndrome (PCOS). PCOS is associated with substantial metabolic and cardiovascular long …
Immunotherapy for autoimmune autonomic ganglionopathy
V Iodice, K Kimpinski, S Vernino, P Sandroni… - Autonomic …, 2009 - Elsevier
PURPOSE OF REVIEW: To provide an update on recent advances in the treatment of
autoimmune autonomic ganglionopathy (AAG). AAG is an immune-mediated disorder …
autoimmune autonomic ganglionopathy (AAG). AAG is an immune-mediated disorder …
Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome
M Moulana - Life sciences, 2019 - Elsevier
The immune etiology of polycystic ovary syndrome (PCOS) is an intriguing area. However,
whether there is alteration in the leukocyte populations in different tissues remain …
whether there is alteration in the leukocyte populations in different tissues remain …
Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis
H Gensicke, D Leppert, O Yaldizli, RLP Lindberg… - CNS drugs, 2012 - Springer
Multiple sclerosis (MS) is an inflammatory and degenerative disease leading to
demyelination and axonal damage in the CNS. Autoimmunity plays a central role in MS …
demyelination and axonal damage in the CNS. Autoimmunity plays a central role in MS …
Treatment of immune‐mediated, dysimmune neuropathies
J Finsterer - Acta neurologica scandinavica, 2005 - Wiley Online Library
This review focuses on the actual status and recent advances in the treatment of immune‐
mediated neuropathies, including: Guillain–Barre syndrome (GBS) with its subtypes acute …
mediated neuropathies, including: Guillain–Barre syndrome (GBS) with its subtypes acute …
Unconventional treatments for chronic inflammatory demyelinating polyneuropathy
YA Rajabally - Neurodegenerative disease management, 2017 - Taylor & Francis
This article focuses on the unconventional treatments used in chronic inflammatory
demyelinating polyneuropathy (CIDP). First line, evidence-based treatments for CIDP …
demyelinating polyneuropathy (CIDP). First line, evidence-based treatments for CIDP …
Biological therapies directed against cells in autoimmune disease
P Hasler - Springer seminars in immunopathology, 2006 - Springer
Among the cells of the immune system involved in the pathogenesis of autoimmune disease,
T cells have received the most attention. The central role of these cells in several animal …
T cells have received the most attention. The central role of these cells in several animal …
Tremor in neuropathies of different origin
A Wasielewska, M Rudzińska… - Neurologia i …, 2013 - journals.viamedica.pl
Background and purpose Tremor accompanies some polyneuropathies, but its prevalence
and its clinical and electrophysiological manifestations are not well known. The aim of the …
and its clinical and electrophysiological manifestations are not well known. The aim of the …